ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Runaway2020
|
108 |
44K |
3 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
108
|
44K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Runaway2020
|
108 |
44K |
4 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
108
|
44K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Runaway2020
|
108 |
44K |
1 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
108
|
44K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Runaway2020
|
108 |
44K |
13 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
108
|
44K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Runaway2020
|
108 |
44K |
16 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
108
|
44K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
Runaway2020
|
88 |
35K |
8 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
35K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
Runaway2020
|
88 |
35K |
2 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
35K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives EMA scientific advice for Phase 3 in MBC
|
|
Runaway2020
|
24 |
9.4K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
24
|
9.4K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives EMA scientific advice for Phase 3 in MBC
|
|
Runaway2020
|
24 |
9.4K |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
24
|
9.4K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Runaway2020
|
17 |
5.2K |
3 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
17
|
5.2K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Runaway2020
|
17 |
5.2K |
2 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
17
|
5.2K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Runaway2020
|
17 |
5.2K |
2 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
17
|
5.2K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
157 |
69K |
7 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
157
|
69K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble Lag-3 Protein, In...
|
|
Runaway2020
|
86 |
30K |
2 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
86
|
30K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted Chinese patent for its LAG-3 candidate Efti
|
|
Runaway2020
|
87 |
40K |
7 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
87
|
40K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 & INSIGHT-004 data to be presented at ASCO
|
|
Runaway2020
|
260 |
103K |
2 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
260
|
103K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Quarterly Activities Report & Appendix 4C
|
|
Runaway2020
|
20 |
9.8K |
16 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
20
|
9.8K
|
16
|
|
ASX - By Stock
|
ECS |
Re:
Re: Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
70 |
10K |
1 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
70
|
10K
|
1
|
|
ASX - By Stock
|
ECS |
Re:
Re: Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
70 |
10K |
4 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
70
|
10K
|
4
|
|
ASX - By Stock
|
ECS |
Re:
Re: Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
70 |
10K |
2 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
70
|
10K
|
2
|
|
ASX - By Stock
|
ECS |
Re:
Re: Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
70 |
10K |
4 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
70
|
10K
|
4
|
|
ASX - By Stock
|
ECS |
Re:
Re: Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
70 |
10K |
3 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
70
|
10K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
Re: Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
70 |
10K |
2 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
70
|
10K
|
2
|
|
ASX - By Stock
|
ECS |
Re:
Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
135 |
23K |
1 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
135
|
23K
|
1
|
|
ASX - By Stock
|
ECS |
Re:
Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
135 |
23K |
2 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
135
|
23K
|
2
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Entitlement Offer Prospectus
|
|
Runaway2020
|
42 |
6.3K |
3 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
42
|
6.3K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
135 |
23K |
6 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
135
|
23K
|
6
|
|
ASX - By Stock
|
ECS |
Re:
Ann: ECS successfully completes $4m raising
|
|
Runaway2020
|
135 |
23K |
6 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
135
|
23K
|
6
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
87 |
18K |
1 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
87
|
18K
|
1
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
87 |
18K |
3 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
87
|
18K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
87 |
18K |
2 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
87
|
18K
|
2
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
87 |
18K |
3 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
87
|
18K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
87 |
18K |
6 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
87
|
18K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Merck US$1.85b takeover of clinical autoimmune biotech company
|
|
Runaway2020
|
42 |
19K |
1 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
42
|
19K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Dream big with Zelira
|
|
Runaway2020
|
1.1K |
421K |
0 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
1.1K
|
421K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Dream big with Zelira
|
|
Runaway2020
|
1.1K |
421K |
2 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
1.1K
|
421K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Enters A Licensing Accord Manufacture and Distribute HOPE Line Of Products In The US
|
|
Runaway2020
|
18 |
6.9K |
0 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
18
|
6.9K
|
0
|
|
ASX - By Stock
|
ECS |
Re:
ECS Chart
|
|
Runaway2020
|
574 |
128K |
9 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
574
|
128K
|
9
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Strategic Transition and Executive Changes
|
|
Runaway2020
|
37 |
14K |
2 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
37
|
14K
|
2
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Runaway2020
|
132 |
33K |
5 |
07/02/21 |
07/02/21 |
ASX - By Stock
|
132
|
33K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Runaway2020
|
1K |
291K |
6 |
06/02/21 |
06/02/21 |
ASX - By Stock
|
1K
|
291K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
445 |
167K |
4 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
445
|
167K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
445 |
167K |
1 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
445
|
167K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
CBD & Cannabidiol now available over the counter
|
|
Runaway2020
|
19 |
6.9K |
1 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
19
|
6.9K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Runaway2020
|
8.9K |
3.3M |
9 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
9
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C - quarterly
|
|
Runaway2020
|
102 |
33K |
7 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
102
|
33K
|
7
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C - quarterly
|
|
Runaway2020
|
102 |
33K |
7 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
102
|
33K
|
7
|
|
ASX - By Stock
|
ZLD |
Re:
ZLD Chart
|
|
Runaway2020
|
847 |
293K |
1 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
847
|
293K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
ZLD Chart
|
|
Runaway2020
|
847 |
293K |
5 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
847
|
293K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Runaway2020
|
8.9K |
3.3M |
8 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
8
|
|